ARCH Venture Partners

ARCH Venture Partners is a premier provider of seed and early stage venture capital for technology firms, with a special competence in co-founding and building firms from start-up.

Our mission is to deliver promising technologies from the earliest stages to successful commercial application – from concept to commerce.

With a 30 year history and $2 billion in capital under management, ARCH has secured its place among the largest providers of seed and early stage capital in the U.S.

TypeInvestor
HQChicago, US
Founded1986
Websitearchventure.com
Cybersecurity ratingAMore
ARCH Venture Partners was founded in 1986 and is headquartered in Chicago, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at ARCH Venture Partners

Kristina Burow

Kristina Burow

Managing Director
Robert Nelsen

Robert Nelsen

Co-Founder & Managing Director
Keith Crandell

Keith Crandell

Co-Founder & Managing Director
Steve Gillis

Steve Gillis

Managing Director
Clinton Bybee

Clinton Bybee

Co-founder & Managing Director, Emeritus
Mark McDonnell

Mark McDonnell

CFO, CAO & Managing Director
Show more

ARCH Venture Partners Office Locations

ARCH Venture Partners has offices in Chicago, San Francisco and Seattle
Chicago, US (HQ)
8755 W Higgins Rd #1025
San Francisco, US
1700 Owens St #535, San Francisco
Seattle, US
188 E Blaine St #125
Show all (3)

ARCH Venture Partners Investment Portfolio

Stage Distribution

19982020

Top Sectors Distribution

20002020

Round Size Distribution

19982020
Show more

ARCH Venture Partners Online and Social Media Presence

Embed Graph

ARCH Venture Partners Blogs

Co-Founder and Managing Director Robert Nelsen Discusses Commitment to Infectious Disease Investing and its Implications amid COVID-19

The post Co-Founder and Managing Director Robert Nelsen Discusses Commitment to Infectious Disease Investing and its Implications amid COVID-19 appeared first on Arch Venture Partners.

Beam Therapeutics – This Startup Might Finally Cure Sickle Cell Disease—After A Century Of Racist Neglect

The post Beam Therapeutics – This Startup Might Finally Cure Sickle Cell Disease—After A Century Of Racist Neglect appeared first on Arch Venture Partners.

Vir – Antibody from SARS Survivor Neutralizes SARS-CoV-2 Live Virus Infection of Cells

The post Vir – Antibody from SARS Survivor Neutralizes SARS-CoV-2 Live Virus Infection of Cells appeared first on Arch Venture Partners.

Mindstrong Raises $100M in Series C Round of Financing

The post Mindstrong Raises $100M in Series C Round of Financing appeared first on Arch Venture Partners.

Rome Therapeutics Launches with $50M to Tackle Small-Molecule Drugs for Cancer

The post Rome Therapeutics Launches with $50M to Tackle Small-Molecule Drugs for Cancer appeared first on Arch Venture Partners.

GlaxoSmithKline and ARCH-backed Vir Aim to Take on Covid-19 with Antibodies and CRISPR

The post GlaxoSmithKline and ARCH-backed Vir Aim to Take on Covid-19 with Antibodies and CRISPR appeared first on Arch Venture Partners.
Show more

ARCH Venture Partners Frequently Asked Questions

  • When was ARCH Venture Partners founded?

    ARCH Venture Partners was founded in 1986.

  • Who are ARCH Venture Partners key executives?

    ARCH Venture Partners's key executives are Kristina Burow, Robert Nelsen and Keith Crandell.

  • Where is ARCH Venture Partners headquarters?

    ARCH Venture Partners headquarters is located at 8755 W Higgins Rd #1025, Chicago.

  • Where are ARCH Venture Partners offices?

    ARCH Venture Partners has offices in Chicago, San Francisco and Seattle.

  • How many offices does ARCH Venture Partners have?

    ARCH Venture Partners has 3 offices.